Collectively, data coming from murine models suggest a weak oncogenic potential for isolated GNAS mutations and a synergistic effect of combined RAS and GNAS alterations on induction of IPMN formation. Here, GNAS is linked to pancreatic intraductal papillary-mucinous neoplasm.